Inventor · disambiguated record
Mahrukh Huseni
Also filed as: HUSENI MAHRUKH
4 granted patents·14 pending applications·1 citations·filing 2015–2025
58Inventor score
Files withGENENTECH INC18
Top patents by PatentIndex Score
18 records- 0176US11402382B2Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2019·Granted Aug 2, 2022·1 cites·9 claims
- 0269US12078638B2Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 0364US12240910B2Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods of useGENENTECH INC·Filed 2022·Granted Mar 4, 2025·0 cites·47 claims
- 0461US2024410013A1Methods and compositions for classifying and treating kidney cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 0558US10767232B2Methods and biomarkers for predicting efficacy and evaluation of an OX40 agonist treatmentGENENTECH INC·Filed 2017·Granted Sep 8, 2020·0 cites·13 claims
- 0657US2024060135A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 0751US2025250347A1Anti-c-c motif chemokine receptor 8 (ccr8) antibodies and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0849US2020157635A1Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2019·Application pending·0 cites
- 0948US2021332143A1Combination therapy for cancer comprising pd-1 axis binding antagonist and il6 antagonistGENENTECH INC·Filed 2021·Application pending·0 cites
- 1046US2018346586A1Methods of treating cancer using anti-ox40 antibodiesGENENTECH INC·Filed 2018·Application pending·0 cites
- 1144US2017290913A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1244US2018256711A1Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonistsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1343US2021253710A1Diagnostic and therapeutic methods for kidney cancerGENENTECH INC·Filed 2021·Application pending·0 cites
- 1440US2016355597A1Methods of treating cancer using anti-ox40 antibodiesGENENTECH INC·Filed 2016·Application pending·0 cites
- 1540US2016166685A1Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonistsGENENTECH INC·Filed 2015·Application pending·0 cites
- 1640US2017000885A1Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonistsGENENTECH INC·Filed 2016·Application pending·0 cites
- 1740US2016160290A1Methods and biomarkers for predicting efficacy and evaluation of an ox40 agonist treatmentGENENTECH INC·Filed 2015·Application pending·0 cites
- 1838US2025297019A1Methods of treating cancer with anti-c-c motif chemokine receptor 8 (ccr8) antibodiesGENENTECH INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mahrukh Huseni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →